Crossmark

Efficiency comparison with fovea-sparing internal limiting membrane peeling and complete internal limiting membrane peeling for treating myopic traction maculopathy

Crossref DOI link: https://doi.org/10.1007/s00417-021-05320-y

Published Online: 2021-07-26

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xin, Wen-Jian

Jiang, Ji-Ze

Ji, Lei-Bing

Lv, Wen-Juan

Gu, Yong-Xin

Xiao, Yun https://orcid.org/0000-0002-6667-0563
License Information

Text and Data Mining valid from 2021-07-26

Version of Record valid from 2021-07-26
More Information

Article History

Received: 23 March 2021

Revised: 17 June 2021

Accepted: 7 July 2021

First Online: 26 July 2021

Declarations

:

: The studies involving human participants were reviewed and approved by the ethics committee of General Hospital of Xinjiang Military Region. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. The study protocol of this study conforms to the ethical guidelines of the 1975 Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below